Abstract
Background: Antibiomania, whereby an antibiotic induces a manic/hypomanic episode in those with or without a pre-existing bipolar condition, is a little-known phenomenon, diagnostically elusive, may be more prevalent than recognised and thus warrants the current overview. Method: Representative studies and clinical observations are noted. Results: Several mechanistic issues are considered but with a weighting to the antibiotic causing gut dysbiosis and so activating gut-brain axis pathways that may induce manic/hypomanic episodes. Conclusion: Future studies should seek to determine the prevalence of antibiomania and whether differing antibiotics effect differential risks, while clinicians identifying such a potential linkage in a patient who has developed a first episode or recurrence of a manic/hypomanic episode should consider nuanced pre-emptive and management strategies in such instances.
Author supplied keywords
Cite
CITATION STYLE
Parker, G., & Russo, N. (2025). Antibiomania: An update. Australasian Psychiatry, 33(5), 797–799. https://doi.org/10.1177/10398562251370946
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.